These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2036915)

  • 21. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical determination of nuclear antigens by colour image analysis: application for labelling index, estrogen and progesterone receptor status in breast cancer.
    Rostagno P; Birtwisle I; Ettore F; Courdi A; Gioanni J; Namer M; Caldani C
    Anal Cell Pathol; 1994 Dec; 7(4):275-87. PubMed ID: 7696153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.
    Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G
    Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry].
    Marcot I; Migeon C; Parache RM; Marchal S; Virion JM
    Bull Cancer; 1997 Jun; 84(6):613-8. PubMed ID: 9295864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunodetection in fine-needle aspirates and multiparametric (SAMBA) image analysis. Receptors (monoclonal antiestrogen and antiprogesterone) and growth fraction (monoclonal Ki67) evaluation in breast carcinomas.
    Charpin C; Andrac L; Habib MC; Vacheret H; Xerri L; Devictor B; Lavaut MN; Toga M
    Cancer; 1989 Mar; 63(5):863-72. PubMed ID: 2644015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
    McClelland RA; Finlay P; Walker KJ; Nicholson D; Robertson JF; Blamey RW; Nicholson RI
    Cancer Res; 1990 Jun; 50(12):3545-50. PubMed ID: 2187598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image cytometry of aneuploidy, growth fraction (MoAb Ki-67) and hormone receptors (ER, PR) immunocytochemical assays in breast carcinomas.
    Charpin C; Andrac L; Lavaut MN; Andonian C; Fraterno M; Devictor B; Perez-Castillo A; Bonnier P; Piana L
    Anal Cell Pathol; 1990 Oct; 2(6):357-71. PubMed ID: 2275882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
    Ferrer Roca OF; Ramos A; Diaz Cardama A
    Anal Cell Pathol; 1995 Sep; 9(2):151-63. PubMed ID: 7492518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prognostic implications of sex-steroid receptors in human cancer.
    McCarty KS; Kinsel LB; Georgiade G; Leight G; McCarty KS
    Prog Clin Biol Res; 1990; 322():279-93. PubMed ID: 2304938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM
    Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study on immunohistochemical detection of estrogen receptor in the breast cancer tissue--a comparison between routinely paraffin-embedded and frozen sections].
    Kawabata K; Watanabe K; Ozaki S
    Rinsho Byori; 1995 Sep; 43(9):960-4. PubMed ID: 7474461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
    Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
    Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer.
    Joshi AS; Sharangpani GM; Porter K; Keyhani S; Morrison C; Basu AS; Gholap GA; Gholap AS; Barsky SH
    Cytometry A; 2007 May; 71(5):273-85. PubMed ID: 17323351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of the immunocytochemical assay for estrogen receptor protein (ER-ICA) in human breast cancer by television imaging.
    Sklarew RJ; Pertschuk LP
    J Histochem Cytochem; 1987 Nov; 35(11):1253-9. PubMed ID: 2821106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.